UK markets close in 7 hours 8 minutes
  • FTSE 100

    7,173.83
    +35.48 (+0.50%)
     
  • FTSE 250

    24,185.27
    -9.34 (-0.04%)
     
  • AIM

    1,311.02
    +0.87 (+0.07%)
     
  • GBP/EUR

    1.1667
    +0.0005 (+0.05%)
     
  • GBP/USD

    1.3843
    -0.0021 (-0.15%)
     
  • BTC-GBP

    37,324.85
    +1,061.19 (+2.93%)
     
  • CMC Crypto 200

    1,354.99
    +57.26 (+4.41%)
     
  • S&P 500

    4,535.43
    -1.52 (-0.03%)
     
  • DOW

    35,369.09
    -74.71 (-0.21%)
     
  • CRUDE OIL

    68.60
    -0.69 (-1.00%)
     
  • GOLD FUTURES

    1,828.30
    -5.40 (-0.29%)
     
  • NIKKEI 225

    29,659.89
    +531.78 (+1.83%)
     
  • HANG SENG

    26,155.92
    +253.93 (+0.98%)
     
  • DAX

    15,873.63
    +92.43 (+0.59%)
     
  • CAC 40

    6,728.61
    +38.62 (+0.58%)
     

Insights on the PCR and NGS-based Diagnostics Global Market to 2027 - Featuring Abbott Laboratories, Thermo Fisher Scientific and Illumina Among Others

·5-min read

Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "PCR and NGS-based Diagnostics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's offering.

The report on the global PCR and NGS-based diagnostics market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global PCR and NGS-based diagnostics market to grow with a CAGR of 10.4% over the forecast period from 2021-2027. The study on PCR and NGS-based diagnostics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on PCR and NGS-based diagnostics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global PCR and NGS-based diagnostics market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global PCR and NGS-based diagnostics market over the period of 2019 to 2027. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rise in the prevalence of infectious diseases

  • Growing R&D and funding in molecular diagnostics

2) Restraints

  • Lack of skilled professionals in low- and middle-income countries

3) Opportunities

  • Transforming healthcare infrastructure in developing regions

Segment Covered

The global PCR and NGS-based diagnostics market is segmented on the basis of product, application, and end user.

The Global PCR and NGS-based Diagnostics Market by Product

  • Reagents & Kits

  • Instruments

  • Services & Software

The Global PCR and NGS-based Diagnostics Market by Application

  • Infectious Disease Diagnostics

  • Genetic Tests

  • Oncology Testing

  • Others

The Global PCR and NGS-based Diagnostics Market by End User

  • Hospitals and Clinics

  • Diagnostic Centers

  • Others

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the PCR and NGS-based diagnostics market.

2. Complete coverage of all the segments in the PCR and NGS-based diagnostics market to analyze the trends, developments in the global market and forecast of market size up to 2027.

3. Comprehensive analysis of the companies operating in the global PCR and NGS-based diagnostics market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global PCR and NGS-based Diagnostics Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the PCR and NGS-based Diagnostics Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Application
3.5.3. Growth Matrix Analysis by End User
3.5.4. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of PCR and NGS-based Diagnostics Market

4. PCR and NGS-based Diagnostics Market Macro Indicator Analysis

5. Global PCR and NGS-based Diagnostics Market by Product
5.1. Reagents & Kits
5.2. Instruments
5.3. Services & Software

6. Global PCR and NGS-based Diagnostics Market by Application
6.1. Infectious Disease Diagnostics
6.2. Genetic Tests
6.3. Oncology Testing
6.4. Others

7. Global PCR and NGS-based Diagnostics Market by End User
7.1. Hospitals and Clinics
7.2. Diagnostic Centers
7.3. Others

8. Global PCR and NGS-based Diagnostics Market by Region 2021-2027
8.1. North America
8.1.1. North America PCR and NGS-based Diagnostics Market by Product
8.1.2. North America PCR and NGS-based Diagnostics Market by Application
8.1.3. North America PCR and NGS-based Diagnostics Market by End User
8.1.4. North America PCR and NGS-based Diagnostics Market by Country
8.2. Europe
8.2.1. Europe PCR and NGS-based Diagnostics Market by Product
8.2.2. Europe PCR and NGS-based Diagnostics Market by Application
8.2.3. Europe PCR and NGS-based Diagnostics Market by End User
8.2.4. Europe PCR and NGS-based Diagnostics Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific PCR and NGS-based Diagnostics Market by Product
8.3.2. Asia-Pacific PCR and NGS-based Diagnostics Market by Application
8.3.3. Asia-Pacific PCR and NGS-based Diagnostics Market by End User
8.3.4. Asia-Pacific PCR and NGS-based Diagnostics Market by Country
8.4. RoW
8.4.1. RoW PCR and NGS-based Diagnostics Market by Product
8.4.2. RoW PCR and NGS-based Diagnostics Market by Application
8.4.3. RoW PCR and NGS-based Diagnostics Market by End User
8.4.4. RoW PCR and NGS-based Diagnostics Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global PCR and NGS-based Diagnostics Market
9.2. Companies Profiled
9.2.1. Bio-Rad Laboratories, Inc.
9.2.2. Eppendorf AG
9.2.3. F. Hoffmann-La Roche AG
9.2.4. Abbott Laboratories, Inc.
9.2.5. Thermo Fisher Scientific Inc.
9.2.6. Illumina Inc.
9.2.7. Agilent Technologies Inc.
9.2.8. QIAGEN
9.2.9. Molbio Diagnostics Pvt. Ltd.
9.2.10. Amoy Diagnostics Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/jggdp9

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting